DE2225548C3 - Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis - Google Patents

Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis

Info

Publication number
DE2225548C3
DE2225548C3 DE2225548A DE2225548A DE2225548C3 DE 2225548 C3 DE2225548 C3 DE 2225548C3 DE 2225548 A DE2225548 A DE 2225548A DE 2225548 A DE2225548 A DE 2225548A DE 2225548 C3 DE2225548 C3 DE 2225548C3
Authority
DE
Germany
Prior art keywords
vaccine
distemper
vaccination
infection
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2225548A
Other languages
German (de)
English (en)
Other versions
DE2225548B2 (de
DE2225548A1 (de
Inventor
Othmar Dr. 3550 Marburg Ackermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Priority to DE2225548A priority Critical patent/DE2225548C3/de
Priority to NL7306986.A priority patent/NL163428C/xx
Priority to AR248179A priority patent/AR201193A1/es
Priority to US363413A priority patent/US3886270A/en
Priority to CA172,332A priority patent/CA1020461A/en
Priority to AU56125/73A priority patent/AU467451B2/en
Priority to ZA733571A priority patent/ZA733571B/xx
Priority to AT459273A priority patent/AT336779B/de
Priority to DK291173A priority patent/DK141055C/da
Priority to BE131601A priority patent/BE800132A/xx
Priority to FR7319343A priority patent/FR2189023B1/fr
Priority to GB2551673A priority patent/GB1437006A/en
Publication of DE2225548A1 publication Critical patent/DE2225548A1/de
Priority to SE7608007A priority patent/SE7608007L/xx
Publication of DE2225548B2 publication Critical patent/DE2225548B2/de
Application granted granted Critical
Publication of DE2225548C3 publication Critical patent/DE2225548C3/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G10—MUSICAL INSTRUMENTS; ACOUSTICS
    • G10L—SPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING
    • G10L15/00—Speech recognition
    • G10L15/22—Procedures used during a speech recognition process, e.g. man-machine dialogue
    • G10L2015/226—Procedures used during a speech recognition process, e.g. man-machine dialogue using non-speech characteristics
    • G10L2015/227—Procedures used during a speech recognition process, e.g. man-machine dialogue using non-speech characteristics of the speaker; Human-factor methodology
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE2225548A 1972-05-26 1972-05-26 Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis Expired DE2225548C3 (de)

Priority Applications (13)

Application Number Priority Date Filing Date Title
DE2225548A DE2225548C3 (de) 1972-05-26 1972-05-26 Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis
NL7306986.A NL163428C (nl) 1972-05-26 1973-05-18 Werkwijze voor het bereiden van een voor intraveneuze toediening geschikt combinatie-vaccin tegen honde- -ziekte en honde-hepatitis.
AR248179A AR201193A1 (es) 1972-05-26 1973-05-23 Procedimiento para la preparacion de una vacuna compatible por via intravenosa contra moquillo y hepatitis contagiosa canis
CA172,332A CA1020461A (en) 1972-05-26 1973-05-24 Intravenously tolerated anti-distemper and anti-hepatitis vaccine, its preparation and its use for immunization
US363413A US3886270A (en) 1972-05-26 1973-05-24 Intravenously tolerated anti-distemper and anti-hepatitis vaccine, its preparation and its use for immunization
ZA733571A ZA733571B (en) 1972-05-26 1973-05-25 Intravenously tolerated anti-distemper and anti-hepatitis vaccine,its preparation and its use for immunization
AU56125/73A AU467451B2 (en) 1972-05-26 1973-05-25 Intravenously tolerated anti-distemper and anti-hepatitis vaccine, its preparation and its use for immunization
AT459273A AT336779B (de) 1972-05-26 1973-05-25 Verfahren zur herstellung einer intravenos vertraglichen vaccine gegen staupe und hepatitis contagiosa canis
DK291173A DK141055C (da) 1972-05-26 1973-05-25 Fremgangsmaade til fremstilling af en intravenoest acceptabel vaccine mod hundesyge og hepatitis contagiosa canis
BE131601A BE800132A (fr) 1972-05-26 1973-05-28 Vaccin contre la maladie des chiens et l'hepatite
FR7319343A FR2189023B1 (OSRAM) 1972-05-26 1973-05-28
GB2551673A GB1437006A (en) 1972-05-26 1973-05-29 Antidistemper and anti-hepatitis vaccines
SE7608007A SE7608007L (sv) 1972-05-26 1976-07-13 Intravenost fordragbart valpsjuke- och hepatitvaccin, forfarande for dess framstellning, och dess anvendning for immunisering

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2225548A DE2225548C3 (de) 1972-05-26 1972-05-26 Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis

Publications (3)

Publication Number Publication Date
DE2225548A1 DE2225548A1 (de) 1973-12-06
DE2225548B2 DE2225548B2 (de) 1979-09-06
DE2225548C3 true DE2225548C3 (de) 1980-05-29

Family

ID=5845894

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2225548A Expired DE2225548C3 (de) 1972-05-26 1972-05-26 Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis

Country Status (13)

Country Link
US (1) US3886270A (OSRAM)
AR (1) AR201193A1 (OSRAM)
AT (1) AT336779B (OSRAM)
AU (1) AU467451B2 (OSRAM)
BE (1) BE800132A (OSRAM)
CA (1) CA1020461A (OSRAM)
DE (1) DE2225548C3 (OSRAM)
DK (1) DK141055C (OSRAM)
FR (1) FR2189023B1 (OSRAM)
GB (1) GB1437006A (OSRAM)
NL (1) NL163428C (OSRAM)
SE (1) SE7608007L (OSRAM)
ZA (1) ZA733571B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL133476B1 (en) * 1981-06-10 1985-06-29 Akad Medyczna Method of obtaining pure antigen hba from human serum
US5000951A (en) * 1987-03-09 1991-03-19 Diamond Scientific Company Multivalent canine distemper virus vaccine
US4990367A (en) * 1987-03-09 1991-02-05 Diamond Scientific Company Canine distemper virus vaccine
CN105884889A (zh) * 2016-04-18 2016-08-24 内蒙古神元生物工程股份有限公司 犬瘟热-传染性肝炎-细小病毒三联卵黄抗体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470294A (en) * 1961-06-21 1969-09-30 Behringwerke Ag Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it
US3316153A (en) * 1965-03-29 1967-04-25 Lilly Co Eli Virus purification
US3519400A (en) * 1967-01-25 1970-07-07 Atomic Energy Commission Method of centrifugal separation and recovery of chemical species utilizing a liquid medium

Also Published As

Publication number Publication date
US3886270A (en) 1975-05-27
DK141055C (da) 1980-06-23
AR201193A1 (es) 1975-02-21
CA1020461A (en) 1977-11-08
AT336779B (de) 1977-05-25
BE800132A (fr) 1973-11-28
DE2225548B2 (de) 1979-09-06
NL163428C (nl) 1980-09-15
SE7608007L (sv) 1976-07-13
DE2225548A1 (de) 1973-12-06
ATA459273A (de) 1976-09-15
NL7306986A (OSRAM) 1973-11-28
NL163428B (nl) 1980-04-15
DK141055B (da) 1979-12-31
GB1437006A (en) 1976-05-26
ZA733571B (en) 1974-04-24
AU5612573A (en) 1974-11-28
AU467451B2 (en) 1975-12-04
FR2189023A1 (OSRAM) 1974-01-25
FR2189023B1 (OSRAM) 1976-12-03

Similar Documents

Publication Publication Date Title
DE2717919A1 (de) Verfahren zur herstellung eines pferde-rhinopneumonievakzins und durch dieses verfahren hergestelltes vakzin
DE2463143C2 (de) Polyvalente Rindervirus-Lebendimpfstoffe
DE2362067C2 (de) Temperaturempfindliche, nicht-pathogene, infektiöse Rinder-Rhinotracheitis-Virusstämme, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Lebendimpfstoffen
DE2323847C3 (de) Lebendimpfstoff zur Immunisierung von Rindern gegen die Parainfluenza-3-Virus-Infektion
DE2225548C3 (de) Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis
DE1924304C3 (de) Diäthylaminoäthyldextran (DEAE-D) als Adjuvans für Impfstoffe zur aktiven Immunisierung von Säugetieren
DE2655691C2 (de) Temperaturempfindliche, vermehrungsfähige, nicht pathogene Varicella-Zoster-Viren, Verfahren zu ihrer Herstellung und diese Viren enthaltende Lebendvaccine
DE2360118B2 (de) Impfstoff gegen Ferkel-Colibacillose
DE1198489B (de) Verfahren zur Herstellung eines Impfstoffes gegen Panleucopenie
DE3784397T2 (de) Lebendvaccine fuer ansteckungskrankheiten von kueken.
DE3122669A1 (de) "verfahren zur herstellung von neuen mutanten von herpes simplex-viren typ 1 und typ 2"
DE2415353C2 (OSRAM)
DE2262427C3 (de) Immunostimulierendes Mittel
DE1950774A1 (de) Heteroploide Zellinien
DE2057544C3 (de) Impfstoff gegen ein neonatales Kälberdiarrhoevirus, Verfahren zu seiner Herstellung und seine Verwendung
DE68927380T2 (de) Impfstoff
CH618091A5 (en) Method for the attenuation of virulent feline rhinotracheitis virus and use of this virus for the production of a vaccine
DE2520310A1 (de) Verfahren zur herstellung von immunisierender milch und/oder kolostrum
Marmorston-Gottesman et al. Immunological Studies in Relation to Suprarenal Gland. VII. Effect of Bilateral Suprarenalectomy on Acquired Resistance in Rats.
DE2700338C2 (de) Parenteral injizierbarer Impfstoff für Schweine gegen Infektionen von Bordetella bronchiseptica sowie Verfahren zum Herstellen dieses Impfstoffes
DE1253412B (de) Verfahren zur Gewinnung eines Impfstoffes gegen infektioese Schweinegastroenteritis
AT234902B (de) Verfahren zur Herstellung einer Vaccine gegen Staupe
DE1792356C2 (de) Staupe-Kombinationsvaccinen und Verfahren zu ihrer Herstellung
DE940315C (de) Verfahren zur Herstellung von Lymphe gegen Schweinepest
DE1902590C2 (de) Verwendung einer Immunribonucleinsäure (IRNS) zum Immunisieren lebender Tiere

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee